Vertex Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

30.10.19	Vertex Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
24.10.19	Vertex In Deal With NHS England For Access To All Licensed CF Medicines (RTTNews)
22.10.19	Odonate On The Move With CONTESSA, FDA Snubs CLSD, It's A Yes For AZN, VRTX (RTTNews)
01.08.19	AMRN'S Vascepa Hits Record Sales, ADMP Slumps On Stock Offering, SRDX On Watch… (RTTNews)
31.07.19	Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
30.04.19	Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
30.04.19	Vertex Pharma: FDA Approves Expanded Indication For KALYDECO - Quick Facts (RTTNews)
02.04.19	Vertex Appoints Charles Wagner As New CFO - Quick Facts (RTTNews)
05.02.19	Vertex Pharmaceuticals Inc. Q4 adjusted earnings Beat Estimates (RTTNews)
24.01.19	Merck KGaA Grants License To Vertex For Two DNA Damage Response Inhibitors (RTTNews)
23.01.19	Vertex Pharmaceuticals Fires COO Ian Smith (RTTNews)
21.01.19	Vertex: EC Approves ORKAMBI To Treat Children With CF Aged 2 To 5 Years Old (RTTNews)
18.12.18	Vertex Pharma Reports Positive Phase 2 Data With VX-150 Proof-of-Concept Study (RTTNews)
13.12.18	Vertex: Health Canada Grants Market Authorization For ORKAMBI In Young Children (RTTNews)
29.11.18	Vertex Pharma Granted Label Extension For KALYDECO In EU - Quick Facts (RTTNews)
27.11.18	Vertex: Two Phase 3 Studies Of VX-659 Triple Combination Met Primary Endpoint (RTTNews)
16.11.18	Vertex Pharma: CHMP Adopts Positive Opinion For ORKAMBI - Quick Facts (RTTNews)
01.11.18	Vertex Pharma: EU Authorizes Cystic Fibrosis Medicine SYMKEVI (RTTNews)
24.10.18	Vertex Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
03.09.18	Vertex Pharma Announces Reimbursement Agreement In Australia For ORKAMBI (RTTNews)
11.08.18	Week Ahead In Pharmaceuticals: 5 Stocks To Watch (REGN, PFE, ALT...) (RTTNews)
08.08.18	BLPH's INOPulse Misses Rhythm, ONCE Bleeds, FDA Panel Nod For INSM (RTTNews)
04.08.18	Week Ahead In Pharmaceuticals - 10 Stocks To Watch (ALNY, INSM, PRTK...) (RTTNews)
30.07.18	European Medicines Agency's CHMP Says Yes To 7 Drugs, No To 1 (RTTNews)
26.07.18	Biotech Stocks Facing FDA Decision In August (RTTNews)
25.07.18	Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
18.06.18	Vertex Reaches Agreement In Sweden For Reimbursement Of ORKAMBI - Quick Facts (RTTNews)
07.06.18	Vertex Pharma Presents Data From KALYDECO Studies - Quick Facts (RTTNews)
26.04.18	Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
05.03.18	New Drugs Approved In February (RTTNews)
01.03.18	Vertex Pharma Begins Phase 3 Study Of VX-659 - Quick Facts (RTTNews)
15.02.18	AMAG Gets FDA Nod, ABMD Hits All-time High, GLMD's NAFLD Trial Flops, NKTR Abuzz (RTTNews)
31.01.18	Vertex Pharma Board Authorizes $500 Mln Share Repurchase Program - Quick Facts (RTTNews)
31.01.18	Vertex Pharmaceuticals Inc. Reveals Advance In Q4 Profit (RTTNews)
26.01.18	Biotech Stocks Facing FDA Decision In February (RTTNews)
22.01.18	Some Branded Drugs Going Generic In 2018 (RTTNews)
10.01.18	Vertex Pharma Granted Extension Of Marketing Authorization For ORKAMBI In Europe (RTTNews)
12.12.17	Vertex, CRISPR Therapeutics To Co-develop And Co-commercialize CTX001 (RTTNews)
07.12.17	Vertex Says Phase 3 Study Of KALYDECO Met Primary Endpoint (RTTNews)
10.11.17	Vertex Receives CHMP Positive Opinion For ORKAMBI - Quick Facts (RTTNews)
25.10.17	Vertex Pharmaceuticals Inc. Earnings Rise 216% In Q3 (RTTNews)
25.08.17	ADMS Soars On FDA Nod, EARS Gets An Earful, Thumbs Up For BIIB's Humira Biosim (RTTNews)
07.08.17	Breakfast Technical Briefing on Biotech Stocks -- Sarepta Therapeutics, Trevena, Tesaro, and Vertex Pharma (PR Newswire)
26.07.17	Vertex Pharmaceuticals Inc. Q2 Income Climbs 71% (RTTNews)
20.07.17	Gainers & Losers Of July 19: AEZS, VRTX, AGRX, PTI, INO... (RTTNews)
19.07.17	Vertex Pulls Back Off Best Levels But Remains Firmly Positive (RTTNews)
19.07.17	FDA Nod For GILD, It's Take 2 For AEZS' Macrilen, VRTX Soars On CF Drug Trials (RTTNews)
18.07.17	Vertex Reports Positive Data From Combination Regimens To Treat Cystic Fibrosis (RTTNews)
30.06.17	Biotech Stock Performance Review -- Vertex Pharma, VIVUS, Xbiotech, and Axovant Sciences (PR Newswire)
09.06.17	Vertex Presents Data On ORKAMBI, KALYDECO At ECFS Conference - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

22:34		Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone
17:58		Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus
17:58		Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX
17:58		Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone
17:56		Novartis-Aktie fester: Novartis passt Umsatzziele nach oben an
16:06		Bayer-Aktie in Rot: FDA erweitert Zulassung für Bayer-Krebsmedikament Nubeqa
15:58		Anleger in Frankfurt halten sich zurück: LUS-DAX liegt nachmittags im Minus
15:58		Donnerstagshandel in Europa: Euro STOXX 50 zeigt sich nachmittags schwächer

22:34

Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone

17:58

Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus

17:58

Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX

17:58

Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone

17:56

Novartis-Aktie fester: Novartis passt Umsatzziele nach oben an

16:06

Bayer-Aktie in Rot: FDA erweitert Zulassung für Bayer-Krebsmedikament Nubeqa